BioDelivery Sciences International (BDSI) News Today → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free BDSI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFlorida International Universityusnews.com - September 14 at 8:58 AMInternational High School for Health Sciencesusnews.com - May 6 at 8:03 AMInternational climate change bodies win humanity awardomaha.com - October 15 at 3:03 PMPerilous Reversal Watch: BioDelivery Sciences International (BDSI)thestreet.com - September 16 at 10:54 PMSciencenpr.org - September 13 at 1:53 PMCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2022 Results - Earnings Call Transcriptseekingalpha.com - May 10 at 10:54 PMJim Cramer's Top Stock Picks: DF MNST BDSIthestreet.com - May 2 at 11:56 PMWhy Collegium Pharmaceutical's Shares Are Trading Higher Todaybenzinga.com - April 5 at 3:09 PMBioDelivery Sciences International (NASDAQ:BDSI) Rating Lowered to Hold at StockNews.commarketbeat.com - March 24 at 1:05 AMBioDelivery Sciences International (NASDAQ:BDSI) Lowered to "Hold" at Truist Financialmarketbeat.com - February 25 at 5:18 PMCardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimatesfinance.yahoo.com - February 24 at 11:36 PMBioDelivery Sciences launches migraine therapy in U.S.seekingalpha.com - February 24 at 1:35 PMBioDelivery Sciences International (BDSI) Just Flashed Golden Cross Signal: Do You Buy?finance.yahoo.com - February 24 at 1:35 PMBioDelivery Sciences International (NASDAQ:BDSI) Lowered to Hold at Cantor Fitzgeraldmarketbeat.com - February 19 at 12:13 PMSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioDelivery Sciences International, Inc. Buyoutstockhouse.com - February 15 at 9:43 PMBDSI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of BioDelivery Sciences International, Inc. Is Fair to Shareholdersapnews.com - February 14 at 6:42 PMBDSI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of BioDelivery Sciences International, Inc. Is Fair to Shareholdersapnews.com - February 14 at 6:42 PMBioDelivery's stock rockets toward a 2-year high after buyout deal with Collegium at a 54% premiumfinance.yahoo.com - February 14 at 8:38 AMWhy the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)finance.yahoo.com - February 7 at 2:06 PMBioDelivery Sciences International (NASDAQ:BDSI) Could Easily Take On More Debtnasdaq.com - February 6 at 2:53 PMShould Value Investors Pick BioDelivery (BDSI) Stock Now?finance.yahoo.com - January 31 at 1:59 PMBioDelivery Sciences International (NASDAQ:BDSI) Price Target Increased to $4.50 by Analysts at HC Wainwrightmarketbeat.com - January 21 at 8:15 AMBioDelivery Sciences International Target of Unusually High Options Trading (NASDAQ:BDSI)marketbeat.com - December 31 at 1:35 PMRaleigh pharma gets favorable ruling in case for drug exclusivityfinance.yahoo.com - December 28 at 2:50 PMWhy BioDelivery Sciences International Stock Was Up 28.5% Mondayfool.com - December 20 at 5:44 PMWhy Is BioDelivery (BDSI) Down 20.8% Since Last Earnings Report?finance.yahoo.com - December 3 at 1:36 PMBioDelivery Sciences International, Inc. (BDSI)finance.yahoo.com - November 17 at 6:13 PMBiodelivery Sciences Intl Insider Makes $320K Stock Purchasefinance.yahoo.com - November 15 at 6:37 PMTuesday 11/9 Insider Buying Report: BDSI, BALYnasdaq.com - November 9 at 3:13 PMBioDelivery Sciences International (BDSI) Tops Q3 Earnings Estimatesfinance.yahoo.com - November 3 at 3:24 PMAnalysts Estimate BioDelivery Sciences International (BDSI) to Report a Decline in Earnings: What to Look Out formsn.com - October 27 at 5:35 PMBioDelivery Sciences Appoints John Golubieski as Chief Financial Officerfinance.yahoo.com - October 21 at 10:09 AMBioDelivery Sciences to Report Third Quarter 2021 Financial Results on November 3, 2021finance.yahoo.com - October 20 at 9:04 AMHere's Why We Think BioDelivery Sciences International (NASDAQ:BDSI) Is Well Worth Watchingfinance.yahoo.com - October 3 at 10:22 AMBioDelivery Sciences International to Host ELYXYB™ Investor Dayfeeds.benzinga.com - September 30 at 8:07 AMBioDelivery Sciences International slips after revenue outlook disappointsseekingalpha.com - September 22 at 6:09 AMBioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the ...apnews.com - September 8 at 6:17 AMBioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conferencefinance.yahoo.com - September 7 at 10:04 AMMarket Cool On BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) Earningsfinance.yahoo.com - September 3 at 10:39 AMBioDelivery Sciences to Participate in Upcoming Virtual Investor Conferencesfinance.yahoo.com - September 3 at 10:39 AMAzurRx BioPharma Announces Appointment of Terry Coelho to its Board of Directorsfinance.yahoo.com - August 16 at 8:08 AMNot Many Are Piling Into BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Just Yetnasdaq.com - August 6 at 11:47 AMBioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB(TM) for the Acute Treatment of Migrainemarketwatch.com - August 5 at 1:17 AMBioDelivery Sciences International, inc (BDSI) Q2 2021 Earnings Call Transcriptfool.com - August 4 at 7:13 PMBioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance Rangemarkets.businessinsider.com - August 4 at 3:16 PMDr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB ...businesswire.com - August 4 at 3:16 PMBioDelivery Sciences Reports Second Quarter 2021 Resultsfinance.yahoo.com - August 4 at 3:16 PMBioDelivery Sciences International, Inc. 2021 Q2 - Results - Earnings Call Presentationseekingalpha.com - August 4 at 10:46 AMBRIEF-BioDelivery Sciences Reports Second Quarter 2021 Resultsmsn.com - August 4 at 10:16 AMHere's what Wall Street expects from Biodelivery Sciences International's earningsmarkets.businessinsider.com - August 2 at 2:26 PM Get BioDelivery Sciences International News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report BDSI Media Mentions By Week BDSI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDSI News Sentiment▼0.000.33▲Average Medical News Sentiment BDSI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDSI Articles This Week▼00▲BDSI Articles Average Week Get BioDelivery Sciences International News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Nektar Therapeutics News Omeros News Immunic News Pacira BioSciences News Supernus Pharmaceuticals News Verve Therapeutics News CureVac News Nuvation Bio News Mineralys Therapeutics News GH Research News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDSI) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioDelivery Sciences International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.